two new drugs for hepatitis C, Incivek (telaprevir, in-SEE-veck) and Victrelis (boceprevir, vic-TREL-is)

You'll hear about two new drugs for hepatitis C, Incivek (telaprevir, in-SEE-veck) and Victrelis (boceprevir, vic-TREL-is).

Hepatitis C is a viral infection that affects the liver...and often leads to chronic liver disease, cirrhosis, and liver cancer.

Victrelis and Incivek are "game changers"...and are bringing up new talks about finally "curing" hepatitis C.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote